TEVA
$40.85-1.11%
as of close, Oct 20, 2026
☾ AH $40.85 -1.11%
Teva Pharmaceutical Industries Limited American Depositary SharesStock · Healthcare
TEVA SEC filings (2026)
CIK 818686 · Pharmaceutical Preparations (SIC 2834) · incorporated in L3 · fiscal year ends in December
2,517 filings on EDGAR since 1996 · 25 annual, 26 quarterly, 1,385 current · financial statements · earnings
Latest 10-K
Feb 3, 2026
fiscal year to Dec 31, 2025
Latest 10-Q
Jul 29, 2026
quarter to Jun 30, 2026
Latest 8-K
Sep 16, 2026
Material definitive agreement; New financial obligation
Last earnings release
Jul 29, 2026
$0.00 vs $0.05 · ▲ 9.6%
Filings on file
2,517
since 1996, 724 insider forms
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
September 2026
- Sep 18Insider saleMIGNONE ROBERTO (Director) sold 367,600 shares for $14.4M at $39.06
- Sep 18Insider saleSavage Brian (Interim Chief Legal Officer) sold 7,342 shares for $285K at $38.69–$39.15
- Sep 168-K8-K · Material definitive agreement; New financial obligation
- Sep 148-K8-K · Other events
- Sep 118-K8-K · Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior NotesRegulation FD disclosure; Other events
- Sep 38-K8-K · Other events
- Sep 38-K8-K · Change to security holders' rights
August 2026
- Aug 21Insider saleWeiss Amir (Chief Accounting Officer) sold 9,445 shares for $355K at $37.61–$37.63
- Aug 21Insider saleSatchi-Fainaro Ronit (Director) sold 415 shares for $15K at $37.25
- Aug 17Insider saleLippman Evan (EVP, Business Development) sold 18,600 shares for $680K at $36.57 under a 10b5-1 plan
- Aug 5Insider saleZaks Tal Zvi (Director) sold 17 shares for $593 at $34.87
- Aug 3Insider saleHughes Eric A (See "Remarks") sold 25,578 shares for $892K at $34.88 under a 10b5-1 plan
- Aug 3Insider saleJover Placid (See "Remarks") sold 12,827 shares for $447K at $34.88 under a 10b5-1 plan
July 2026
June 2026
- Jun 18Insider saleShields Matthew (EVP, Global Operations) sold 9,989 shares for $322K at $32.19
- Jun 11Insider saleKalif Eliyahu Sharon (EVP, Chief Financial Officer) sold 106,563 shares for $3.6M at $34.10 under a 10b5-1 plan
- Jun 5Insider saleFrancis Richard D (President and CEO) sold 6,153 shares for $211K at $34.35 under a 10b5-1 plan
- Jun 3Insider saleShields Matthew (EVP, Global Operations) sold 16,195 shares for $532K at $32.87 under a 10b5-1 plan
May 2026
- May 288-K8-K · Shareholder vote results
- May 14Insider saleKalif Eliyahu Sharon (EVP, Chief Financial Officer) sold 153,251 shares for $5.5M at $35.61 under a 10b5-1 plan
- May 14Insider saleLippman Evan (EVP, Business Development) sold 41,658 shares for $1.5M at $35.58 under a 10b5-1 plan
- May 6Insider saleWeiss Amir (Chief Accounting Officer) sold 10,679 shares for $384K at $36.00
- May 5Insider saleDaniell Richard (EVP, Europe Commercial) sold 30,000 shares for $1.1M at $35.40
- May 1Insider saleSabag Mark (See "Remarks") sold 144,180 shares for $5.0M at $34.99
April 2026
March 2026
- Mar 31ProxyProxy · Additional proxy materials
- Mar 31ProxyProxy · Annual report to shareholders
- Mar 31ProxyProxy · Proxy statement
- Mar 17Insider saleSabag Mark (See "Remarks") sold 62,102 shares for $1.9M at $30.14
- Mar 5Insider saleFrancis Richard D (President and CEO) sold 20,025 shares for $634K at $31.67 under a 10b5-1 plan
- Mar 5Insider saleShields Matthew (EVP, Global Operations) sold 17,295 shares for $548K at $31.67 under a 10b5-1 plan
- Mar 5Insider saleDaniell Richard (EVP, Europe Commercial) sold 17,295 shares for $548K at $31.67 under a 10b5-1 plan
- Mar 5Insider saleJover Placid (See "Remarks") sold 14,150 shares for $448K at $31.67 under a 10b5-1 plan
- Mar 5Insider saleHughes Eric A (See "Remarks") sold 9,533 shares for $302K at $31.67 under a 10b5-1 plan
- Mar 5Insider saleFox Christine (EVP, U.S. Commercial) sold 7,924 shares for $251K at $31.67 under a 10b5-1 plan
- Mar 5Insider saleSavage Brian (Interim Chief Legal Officer) sold 1,127 shares for $36K at $31.67
- Mar 4Insider saleDaniell Richard (EVP, Europe Commercial) sold 91,345 shares for $3.0M at $32.46–$32.95 under a 10b5-1 plan
- Mar 4Insider saleFrancis Richard D (President and CEO) sold 23,393 shares for $759K at $32.46 under a 10b5-1 plan
- Mar 4Insider saleHughes Eric A (See "Remarks") sold 11,277 shares for $366K at $32.46 under a 10b5-1 plan
- Mar 4Insider saleFox Christine (EVP, U.S. Commercial) sold 9,098 shares for $295K at $32.46 under a 10b5-1 plan
- Mar 4Insider saleSavage Brian (Interim Chief Legal Officer) sold 2,675 shares for $87K at $32.46
- Mar 3Insider saleFrancis Richard D (President and CEO) sold 442,935 shares for $14.3M at $32.36 under a 10b5-1 plan
- Mar 3Insider saleDaniell Richard (EVP, Europe Commercial) sold 128,985 shares for $4.2M at $32.36 under a 10b5-1 plan
- Mar 3Insider saleHughes Eric A (See "Remarks") sold 80,762 shares for $2.6M at $32.36 under a 10b5-1 plan
- Mar 3Insider saleSavage Brian (Interim Chief Legal Officer) sold 1,274 shares for $41K at $32.36
February 2026
- Feb 26Insider saleKalif Eliyahu Sharon (EVP, Chief Financial Officer) sold 345,810 shares for $11.6M at $33.64 under a 10b5-1 plan
- Feb 15Insider saleFrancis Richard D (President and CEO) sold 447,778 shares for $15.3M at $34.22 under a 10b5-1 plan
- Feb 3ReportAnnual report, FY2025 — revenue $17.26B (+4% y/y), net income $1.41B, EPS $1.21
January 2026
December 2025
- Dec 118-K8-K · Material definitive agreement; New financial obligation
November 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $93.2M in 37 sales and bought nothing on the open market; 109 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Sep 18, 2026Form 4 | MIGNONE ROBERTODirectorSold · $14.4M · 367,600 sh |
| Sep 18, 2026Form 4 | Savage BrianInterim Chief Legal OfficerSold · $285K · 7,342 sh |
| Aug 21, 2026Form 4 | Weiss AmirChief Accounting OfficerSold · $355K · 9,445 sh |
| Aug 21, 2026Form 4 | Satchi-Fainaro RonitDirectorSold · $15K · 415 sh |
| Aug 17, 2026Form 4 | Lippman EvanEVP, Business DevelopmentSold · $680K · 18,600 sh · 10b5-1 |
| Aug 5, 2026Form 4 | Zaks Tal ZviDirectorSold · $593 · 17 sh |
| Aug 3, 2026Form 4 | Hughes Eric ASee "Remarks"Sold · $892K · 25,578 sh · 10b5-1 |
| Aug 3, 2026Form 4 | Jover PlacidSee "Remarks"Sold · $447K · 12,827 sh · 10b5-1 |
| Jun 18, 2026Form 4 | Shields MatthewEVP, Global OperationsSold · $322K · 9,989 sh |
| Jun 11, 2026Form 4 | Kalif Eliyahu SharonEVP, Chief Financial OfficerSold · $3.6M · 106,563 sh · 10b5-1 |
| Jun 5, 2026Form 4 | Francis Richard DPresident and CEOSold · $211K · 6,153 sh · 10b5-1 |
| Jun 3, 2026Form 4 | Shields MatthewEVP, Global OperationsSold · $532K · 16,195 sh · 10b5-1 |
| May 14, 2026Form 4 | Kalif Eliyahu SharonEVP, Chief Financial OfficerSold · $5.5M · 153,251 sh · 10b5-1 |
| May 14, 2026Form 4 | Lippman EvanEVP, Business DevelopmentSold · $1.5M · 41,658 sh · 10b5-1 |
| May 6, 2026Form 4 | Weiss AmirChief Accounting OfficerSold · $384K · 10,679 sh |
| May 5, 2026Form 4 | Daniell RichardEVP, Europe CommercialSold · $1.1M · 30,000 sh |
| May 1, 2026Form 4 | Sabag MarkSee "Remarks"Sold · $5.0M · 144,180 sh |
| Apr 30, 2026Form 4 | Fox ChristineEVP, U.S. CommercialSold · $751K · 21,258 sh |
| Mar 17, 2026Form 4 | Sabag MarkSee "Remarks"Sold · $1.9M · 62,102 sh |
| Mar 5, 2026Form 4 | Francis Richard DPresident and CEOSold · $634K · 20,025 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Shields MatthewEVP, Global OperationsSold · $548K · 17,295 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Daniell RichardEVP, Europe CommercialSold · $548K · 17,295 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Jover PlacidSee "Remarks"Sold · $448K · 14,150 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Hughes Eric ASee "Remarks"Sold · $302K · 9,533 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Fox ChristineEVP, U.S. CommercialSold · $251K · 7,924 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Savage BrianInterim Chief Legal OfficerSold · $36K · 1,127 sh |
| Mar 4, 2026Form 4 | Daniell RichardEVP, Europe CommercialSold · $3.0M · 91,345 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Francis Richard DPresident and CEOSold · $759K · 23,393 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Hughes Eric ASee "Remarks"Sold · $366K · 11,277 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Fox ChristineEVP, U.S. CommercialSold · $295K · 9,098 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Savage BrianInterim Chief Legal OfficerSold · $87K · 2,675 sh |
| Mar 3, 2026Form 4 | Francis Richard DPresident and CEOSold · $14.3M · 442,935 sh · 10b5-1 |
| Mar 3, 2026Form 4 | Daniell RichardEVP, Europe CommercialSold · $4.2M · 128,985 sh · 10b5-1 |
| Mar 3, 2026Form 4 | Hughes Eric ASee "Remarks"Sold · $2.6M · 80,762 sh · 10b5-1 |
| Mar 3, 2026Form 4 | Savage BrianInterim Chief Legal OfficerSold · $41K · 1,274 sh |
| Feb 26, 2026Form 4 | Kalif Eliyahu SharonEVP, Chief Financial OfficerSold · $11.6M · 345,810 sh · 10b5-1 |
| Feb 15, 2026Form 4 | Francis Richard DPresident and CEOSold · $15.3M · 447,778 sh · 10b5-1 |
Awards, exercises, withholding and plan purchases · 109 transactions
| Date | Insider |
|---|---|
| Sep 18, 2026Form 4 | Savage BrianInterim Chief Legal OfficerExercise or conversion · $156K · 4,503 sh |
| Sep 18, 2026Form 4 | Savage BrianInterim Chief Legal OfficerExercise or conversion · Stock Options (right to buy) · $156K · 4,503 sh |
| Aug 21, 2026Form 4 | Weiss AmirChief Accounting OfficerExercise or conversion · $49K · 2,500 sh |
| Aug 21, 2026Form 4 | Weiss AmirChief Accounting OfficerExercise or conversion · Stock Options (right to buy) · $48K · 2,500 sh |
| Aug 3, 2026Form 4 | Hughes Eric ASee "Remarks"Exercise or conversion · — · 52,744 sh · 10b5-1 |
| Aug 3, 2026Form 4 | Hughes Eric ASee "Remarks"Exercise or conversion · Restricted Share Units · $0 · 52,744 sh · 10b5-1 |
| Aug 3, 2026Form 4 | Jover PlacidSee "Remarks"Exercise or conversion · — · 12,827 sh · 10b5-1 |
| Aug 3, 2026Form 4 | Jover PlacidSee "Remarks"Exercise or conversion · Restricted Share Units · $0 · 12,827 sh · 10b5-1 |
| Jun 5, 2026Form 4 | BARER SOL JDirectorExercise or conversion · — · 21,739 sh |
| Jun 5, 2026Form 4 | BARER SOL JDirectorExercise or conversion · Restricted Share Units · $0 · 21,739 sh |
| Jun 5, 2026Form 4 | MIGNONE ROBERTODirectorExercise or conversion · — · 14,492 sh |
| Jun 5, 2026Form 4 | MIGNONE ROBERTODirectorExercise or conversion · Restricted Share Units · $0 · 14,492 sh |
| Jun 5, 2026Form 4 | Zaks Tal ZviDirectorExercise or conversion · — · 14,492 sh |
| Jun 5, 2026Form 4 | Zaks Tal ZviDirectorExercise or conversion · Restricted Share Units · $0 · 14,492 sh |
| Jun 5, 2026Form 4 | Satchi-Fainaro RonitDirectorExercise or conversion · — · 14,492 sh |
| Jun 5, 2026Form 4 | Satchi-Fainaro RonitDirectorExercise or conversion · Restricted Share Units · $0 · 14,492 sh |
| Jun 5, 2026Form 4 | Nisen PerryDirectorExercise or conversion · — · 14,492 sh |
| Jun 5, 2026Form 4 | Nisen PerryDirectorExercise or conversion · Restricted Share Units · $0 · 14,492 sh |
| Jun 5, 2026Form 4 | LIEBERMAN GERALD MDirectorExercise or conversion · — · 14,492 sh |
| Jun 5, 2026Form 4 | LIEBERMAN GERALD MDirectorExercise or conversion · Restricted Share Units · $0 · 14,492 sh |
| Jun 5, 2026Form 4 | Elstein AmirDirectorExercise or conversion · — · 14,492 sh |
| Jun 5, 2026Form 4 | Elstein AmirDirectorExercise or conversion · Restricted Share Units · $0 · 14,492 sh |
| Jun 5, 2026Form 4 | Crane Rosemary ADirectorExercise or conversion · — · 14,492 sh |
| Jun 5, 2026Form 4 | Crane Rosemary ADirectorExercise or conversion · Restricted Share Units · $0 · 14,492 sh |
| Jun 5, 2026Form 4 | Lichtenstein ChenDirectorExercise or conversion · — · 14,492 sh |
| Jun 5, 2026Form 4 | Lichtenstein ChenDirectorExercise or conversion · Restricted Share Units · $0 · 14,492 sh |
| Jun 5, 2026Form 4 | Francis Richard DPresident and CEOExercise or conversion · — · 13,043 sh · 10b5-1 |
| Jun 5, 2026Form 4 | Francis Richard DPresident and CEOExercise or conversion · Restricted Share Units · $0 · 13,043 sh · 10b5-1 |
| Jun 3, 2026Form 4 | Shields MatthewEVP, Global OperationsExercise or conversion · — · 16,195 sh · 10b5-1 |
| Jun 3, 2026Form 4 | Shields MatthewEVP, Global OperationsExercise or conversion · Restricted Share Units · $0 · 16,195 sh · 10b5-1 |
| May 28, 2026Form 4 | BARER SOL JDirectorAward · Restricted Share Units · $0 · 10,863 sh |
| May 28, 2026Form 4 | MIGNONE ROBERTODirectorAward · Restricted Share Units · $0 · 7,242 sh |
| May 28, 2026Form 4 | Lichtenstein ChenDirectorAward · Restricted Share Units · $0 · 7,242 sh |
| May 28, 2026Form 4 | Crane Rosemary ADirectorAward · Restricted Share Units · $0 · 7,242 sh |
| May 28, 2026Form 4 | Elstein AmirDirectorAward · Restricted Share Units · $0 · 7,242 sh |
| May 28, 2026Form 4 | LIEBERMAN GERALD MDirectorAward · Restricted Share Units · $0 · 7,242 sh |
| May 28, 2026Form 4 | Nisen PerryDirectorAward · Restricted Share Units · $0 · 7,242 sh |
| May 28, 2026Form 4 | Satchi-Fainaro RonitDirectorAward · Restricted Share Units · $0 · 7,242 sh |
| May 28, 2026Form 4 | Zaks Tal ZviDirectorAward · Restricted Share Units · $0 · 7,242 sh |
| May 14, 2026Form 4 | Lippman EvanEVP, Business DevelopmentExercise or conversion · — · 85,849 sh · 10b5-1 |
| May 14, 2026Form 4 | Lippman EvanEVP, Business DevelopmentExercise or conversion · Restricted Share Units · $0 · 85,849 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Francis Richard DPresident and CEOExercise or conversion · — · 42,452 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Francis Richard DPresident and CEOExercise or conversion · Restricted Share Units · $0 · 42,452 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Kalif Eliyahu SharonEVP, Chief Financial OfficerExercise or conversion · — · 19,916 sh |
| Mar 5, 2026Form 4 | Kalif Eliyahu SharonEVP, Chief Financial OfficerExercise or conversion · Restricted Share Units · $0 · 19,916 sh |
| Mar 5, 2026Form 4 | Hughes Eric ASee "Remarks"Exercise or conversion · — · 19,654 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Hughes Eric ASee "Remarks"Exercise or conversion · Restricted Share Units · $0 · 19,654 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Fox ChristineEVP, U.S. CommercialExercise or conversion · — · 17,819 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Fox ChristineEVP, U.S. CommercialExercise or conversion · Restricted Share Units · $0 · 17,819 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Shields MatthewEVP, Global OperationsExercise or conversion · — · 17,295 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Shields MatthewEVP, Global OperationsExercise or conversion · Restricted Share Units · $0 · 17,295 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Daniell RichardEVP, Europe CommercialExercise or conversion · — · 17,295 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Daniell RichardEVP, Europe CommercialExercise or conversion · Restricted Share Units · $0 · 17,295 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Sabag MarkSee "Remarks"Exercise or conversion · — · 15,723 sh |
| Mar 5, 2026Form 4 | Sabag MarkSee "Remarks"Exercise or conversion · Restricted Share Units · $0 · 15,723 sh |
| Mar 5, 2026Form 4 | Jover PlacidSee "Remarks"Exercise or conversion · — · 14,150 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Jover PlacidSee "Remarks"Exercise or conversion · Restricted Share Units · $0 · 14,150 sh · 10b5-1 |
| Mar 5, 2026Form 4 | Savage BrianInterim Chief Legal OfficerExercise or conversion · — · 3,580 sh |
| Mar 5, 2026Form 4 | Savage BrianInterim Chief Legal OfficerExercise or conversion · Restricted Share Units · $0 · 3,580 sh |
| Mar 5, 2026Form 4 | Weiss AmirChief Accounting OfficerExercise or conversion · — · 3,537 sh |
| Mar 5, 2026Form 4 | Weiss AmirChief Accounting OfficerExercise or conversion · Restricted Share Units · $0 · 3,537 sh |
| Mar 4, 2026Form 4 | Francis Richard DPresident and CEOAward · Restricted Share Units · $0 · 136,736 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Kalif Eliyahu SharonEVP, Chief Financial OfficerExercise or conversion · — · 56,763 sh |
| Mar 4, 2026Form 4 | Kalif Eliyahu SharonEVP, Chief Financial OfficerExercise or conversion · Restricted Share Units · $0 · 56,763 sh |
| Mar 4, 2026Form 4 | Daniell RichardEVP, Europe CommercialExercise or conversion · — · 53,973 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Daniell RichardEVP, Europe CommercialExercise or conversion · Restricted Share Units · $0 · 53,973 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Kalif Eliyahu SharonEVP, Chief Financial OfficerAward · Restricted Share Units · $0 · 53,175 sh |
| Mar 4, 2026Form 4 | Sabag MarkSee "Remarks"Exercise or conversion · — · 52,113 sh |
| Mar 4, 2026Form 4 | Sabag MarkSee "Remarks"Exercise or conversion · Restricted Share Units · $0 · 52,113 sh |
| Mar 4, 2026Form 4 | Fox ChristineEVP, U.S. CommercialAward · Restricted Share Units · $0 · 50,643 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Hughes Eric ASee "Remarks"Award · Restricted Share Units · $0 · 50,643 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Francis Richard DPresident and CEOExercise or conversion · — · 50,223 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Francis Richard DPresident and CEOExercise or conversion · Restricted Share Units · $0 · 50,223 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Jover PlacidSee "Remarks"Award · Restricted Share Units · $0 · 37,982 sh |
| Mar 4, 2026Form 4 | Shields MatthewEVP, Global OperationsAward · Restricted Share Units · $0 · 33,424 sh |
| Mar 4, 2026Form 4 | Daniell RichardEVP, Europe CommercialAward · Restricted Share Units · $0 · 33,424 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Sabag MarkSee "Remarks"Award · Restricted Share Units · $0 · 30,385 sh |
| Mar 4, 2026Form 4 | Lippman EvanEVP, Business DevelopmentAward · Restricted Share Units · $0 · 27,347 sh |
| Mar 4, 2026Form 4 | Hughes Eric ASee "Remarks"Exercise or conversion · — · 23,251 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Hughes Eric ASee "Remarks"Exercise or conversion · Restricted Share Units · $0 · 23,251 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Fox ChristineEVP, U.S. CommercialExercise or conversion · — · 20,461 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Fox ChristineEVP, U.S. CommercialExercise or conversion · Restricted Share Units · $0 · 20,461 sh · 10b5-1 |
| Mar 4, 2026Form 4 | Weiss AmirChief Accounting OfficerExercise or conversion · — · 16,329 sh |
| Mar 4, 2026Form 4 | Weiss AmirChief Accounting OfficerExercise or conversion · Restricted Share Units · $0 · 16,329 sh |
| Mar 4, 2026Form 4 | Weiss AmirChief Accounting OfficerAward · Restricted Share Units · $0 · 11,280 sh |
| Mar 4, 2026Form 4 | Savage BrianInterim Chief Legal OfficerAward · Restricted Share Units · $0 · 11,280 sh |
| Mar 4, 2026Form 4 | Savage BrianInterim Chief Legal OfficerExercise or conversion · Restricted Share Units · $0 · 8,510 sh |
| Mar 4, 2026Form 4 | Savage BrianInterim Chief Legal OfficerExercise or conversion · — · 8,210 sh |
| Mar 3, 2026Form 4 | Francis Richard DPresident and CEOExercise or conversion · — · 958,546 sh · 10b5-1 |
| Mar 3, 2026Form 4 | Francis Richard DPresident and CEOExercise or conversion · Restricted Share Units · $0 · 958,546 sh · 10b5-1 |
| Mar 3, 2026Form 4 | Daniell RichardEVP, Europe CommercialExercise or conversion · — · 203,728 sh · 10b5-1 |
| Mar 3, 2026Form 4 | Daniell RichardEVP, Europe CommercialExercise or conversion · Restricted Share Units · $0 · 203,728 sh · 10b5-1 |
| Mar 3, 2026Form 4 | Kalif Eliyahu SharonEVP, Chief Financial OfficerExercise or conversion · — · 191,278 sh |
| Mar 3, 2026Form 4 | Kalif Eliyahu SharonEVP, Chief Financial OfficerExercise or conversion · Restricted Share Units · $0 · 191,278 sh |
| Mar 3, 2026Form 4 | Hughes Eric ASee "Remarks"Exercise or conversion · — · 166,378 sh · 10b5-1 |
| Mar 3, 2026Form 4 | Hughes Eric ASee "Remarks"Exercise or conversion · Restricted Share Units · $0 · 166,378 sh · 10b5-1 |
| Mar 3, 2026Form 4 | Sabag MarkSee "Remarks"Exercise or conversion · — · 166,378 sh |
| Mar 3, 2026Form 4 | Sabag MarkSee "Remarks"Exercise or conversion · Restricted Share Units · $0 · 166,378 sh |
| Mar 3, 2026Form 4 | Weiss AmirChief Accounting OfficerExercise or conversion · — · 5,179 sh |
| Mar 3, 2026Form 4 | Weiss AmirChief Accounting OfficerExercise or conversion · Restricted Share Units · $0 · 5,179 sh |
| Mar 3, 2026Form 4 | Savage BrianInterim Chief Legal OfficerExercise or conversion · — · 3,461 sh |
| Mar 3, 2026Form 4 | Savage BrianInterim Chief Legal OfficerExercise or conversion · Restricted Share Units · $0 · 3,461 sh |
| Feb 15, 2026Form 4 | Francis Richard DPresident and CEOExercise or conversion · — · 781,766 sh · 10b5-1 |
| Feb 15, 2026Form 4 | Francis Richard DPresident and CEOExercise or conversion · Restricted Share Units · $0 · 781,766 sh · 10b5-1 |
| Jan 27, 2026Form 4 | Francis Richard DPresident and CEOAward · Restricted Share Units · $0 · 1,511,425 sh |
| Jan 27, 2026Form 4 | Daniell RichardExec. VP, European CommercialAward · Restricted Share Units · $0 · 141,478 sh |
| Jan 27, 2026Form 4 | Sabag MarkSee "Remarks"Award · Restricted Share Units · $0 · 141,478 sh |
| Jan 27, 2026Form 4 | Hughes Eric ASee "Remarks"Award · Restricted Share Units · $0 · 141,478 sh |
| Jan 27, 2026Form 4 | Kalif Eliyahu SharonEVP, Chief Financial OfficerAward · Restricted Share Units · $0 · 141,478 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 16 filings
| Filed | What it is |
|---|---|
| Sep 16, 20268-K | Material definitive agreement; New financial obligation |
| Sep 14, 20268-K | Other events |
| Sep 11, 20268-K | Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior NotesRegulation FD disclosure; Other events |
| Sep 3, 20268-K | Other events |
| Sep 3, 20268-K | Change to security holders' rights |
| Jul 29, 202610-Q | Quarterly report, Q2 2026 — revenue $4.14B (−1% y/y), net income −$576.0M, EPS −$0.49 |
| Jul 29, 20268-K | Earnings release — EPS $0.00 vs $0.05 est. (−100.0%); revenue $4.14B (−1% y/y) 9.6% |
| May 28, 20268-K | Shareholder vote results |
| Apr 29, 202610-Q | Quarterly report, Q1 2026 — revenue $3.98B (+2% y/y), net income $369.0M, EPS $0.31 |
| Apr 29, 20268-K | Earnings release — EPS $0.50 vs $0.49 est. (+2.0%); revenue $3.98B (+2% y/y) 11.9% |
| Mar 31, 2026DEFA14A | Additional proxy materials |
| Mar 31, 2026ARS | Annual report to shareholders |
| Mar 31, 2026DEF 14A | Proxy statement |
| Feb 3, 202610-K | Annual report, FY2025 — revenue $17.26B (+4% y/y), net income $1.41B, EPS $1.21 |
| Jan 28, 20268-K | Earnings release — EPS $0.93 vs $0.63 est. (+47.6%); revenue $4.71B (+11% y/y) 2.1% |
| Jan 12, 20268-K | Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through InnovationResults of operations |
2025 · 15 filings
| Filed | What it is |
|---|---|
| Dec 11, 20258-K | Material definitive agreement; New financial obligation |
| Nov 5, 202510-Q | Quarterly report, Q3 2025 — revenue $4.48B (+3% y/y), net income $433.0M, EPS $0.37 |
| Nov 5, 20258-K | Earnings release — EPS $0.75 vs $0.66 est. (+13.6%); revenue $4.48B (+3% y/y) 20.2% |
| Jul 30, 202510-Q | Quarterly report, Q2 2025 — revenue $4.18B (+0% y/y), net income $282.0M, EPS $0.24 |
| Jul 30, 20258-K | Earnings release — EPS $0.64 vs $0.60 est. (+6.7%); revenue $4.18B (+0% y/y) 1.8% |
| Jun 5, 20258-K | Shareholder vote results |
| May 28, 20258-K | Material definitive agreement; New financial obligation |
| May 22, 20258-K | Regulation FD disclosure; Other events |
| May 7, 202510-Q | Quarterly report, Q1 2025 — revenue $3.89B (+2% y/y), net income $214.0M, EPS $0.18 |
| May 7, 20258-K | Earnings release — EPS $0.49 vs $0.47 est. (+4.3%); revenue $3.89B (+2% y/y) 9.2% |
| Apr 9, 2025DEFA14A | Additional proxy materials |
| Apr 9, 2025ARS | Annual report to shareholders |
| Apr 9, 2025DEF 14A | Proxy statement |
| Feb 5, 202510-K | Annual report, FY2024 — revenue $16.54B (+4% y/y), net income −$1.64B, EPS −$1.45 |
| Jan 29, 20258-K | Earnings release — EPS $0.70 vs $0.66 est. (+6.1%); revenue $4.23B (−5% y/y) 13.9% |
2024 · 16 filings
| Filed | What it is |
|---|---|
| Nov 12, 20248-K | Directors or officers; compensation |
| Nov 6, 202410-Q | Quarterly report, Q3 2024 — revenue $4.33B (+13% y/y), net income −$437.0M, EPS −$0.39 |
| Nov 6, 20248-K | Earnings release — EPS $0.67 vs $0.63 est. (+6.3%); revenue $4.33B (+13% y/y) 7.1% |
| Jul 31, 202410-Q | Quarterly report, Q2 2024 — revenue $4.16B (+7% y/y), net income −$846.0M, EPS −$0.75 |
| Jul 31, 20248-K | Earnings release — EPS $0.58 vs $0.55 est. (+5.5%); revenue $4.16B (+7% y/y) 6.2% |
| Jun 25, 20248-K | Material definitive agreement |
| Jun 6, 20248-K | Shareholder vote results |
| May 15, 20248-K | Directors or officers; compensation; Regulation FD disclosure |
| May 8, 202410-Q | Quarterly report, Q1 2024 — revenue $3.82B (+4% y/y), net income −$139.0M, EPS −$0.12 |
| May 8, 20248-K | Earnings release — EPS $0.46 vs $0.49 est. (−6.1%); revenue $3.82B (+4% y/y) 12.8% |
| Apr 18, 20248-K | Regulation FD disclosure |
| Apr 16, 2024DEFA14A | Additional proxy materials |
| Apr 16, 2024ARS | Annual report to shareholders |
| Apr 16, 2024DEF 14A | Proxy statement |
| Feb 12, 202410-K | Annual report, FY2023 — revenue $15.85B (+6% y/y), net income −$559.0M, EPS −$0.50 |
| Jan 31, 20248-K | Earnings release — EPS $0.98 vs $0.73 est. (+34.3%); revenue $4.46B (+15% y/y) 3.2% |
2023 · 21 filings — 13 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Nov 9, 202310-Q | Quarterly report, Q3 2023 — revenue $3.85B (+7% y/y), net income $69.0M, EPS $0.06 |
| Aug 2, 202310-Q | Quarterly report, Q2 2023 — revenue $3.88B (+2% y/y), net income −$872.0M, EPS −$0.78 |
| May 24, 2023DEFA14A | Additional proxy materials |
| May 10, 202310-Q | Quarterly report, Q1 2023 — revenue $3.66B (+0% y/y), net income −$220.0M, EPS −$0.20 |
| Apr 19, 2023ARS | Annual report to shareholders |
| Apr 19, 2023DEFA14A | Additional proxy materials |
| Apr 19, 2023DEF 14A | Proxy statement |
| Feb 10, 202310-K | Annual report, FY2022 — revenue $14.93B (−6% y/y), net income −$2.45B, EPS −$2.20 |
13 current reports (8-K) not listed; the year is on EDGAR.
2022 · 14 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Nov 3, 202210-Q | Quarterly report, Q3 2022 — revenue $3.60B (−8% y/y), net income $61.0M, EPS $0.05 |
| Jul 27, 202210-Q | Quarterly report, Q2 2022 — revenue $3.79B (−3% y/y), net income −$251.0M, EPS −$0.23 |
| May 3, 202210-Q | Quarterly report, Q1 2022 — revenue $3.66B (−8% y/y), net income −$955.0M, EPS −$0.86 |
| Apr 13, 2022DEFA14A | Additional proxy materials |
| Apr 13, 2022DEF 14A | Proxy statement |
| Mar 15, 2022PRE 14A | Preliminary proxy statement |
| Feb 9, 202210-K | Annual report, FY2021 — revenue $15.88B (−5% y/y), net income $417.0M, EPS $0.38 |
7 current reports (8-K) not listed; the year is on EDGAR.
2021 · 20 filings — 14 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Oct 27, 202110-Q | Quarterly report, Q3 2021 — revenue $3.89B (−2% y/y), net income $292.0M, EPS $0.26 |
| Jul 28, 202110-Q | Quarterly report, Q2 2021 — revenue $3.91B (+1% y/y), net income $207.0M, EPS $0.19 |
| Apr 28, 202110-Q | Quarterly report, Q1 2021 — revenue $3.98B (−9% y/y), net income $77.0M, EPS $0.07 |
| Apr 21, 2021DEFA14A | Additional proxy materials |
| Apr 21, 2021DEF 14A | Proxy statement |
| Feb 10, 202110-K | Annual report, FY2020 — revenue $16.66B (−1% y/y), net income −$3.99B, EPS −$3.64 |
14 current reports (8-K) not listed; the year is on EDGAR.
2020 · 14 filings — 6 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Nov 5, 202010-Q | Quarterly report, Q3 2020 — revenue $3.98B (−3% y/y), net income −$4.35B, EPS −$3.97 |
| Aug 5, 202010-Q | Quarterly report, Q2 2020 — revenue $3.87B (−7% y/y), net income $140.0M, EPS $0.13 |
| May 26, 2020DEFA14A | Additional proxy materials |
| May 7, 202010-Q | Quarterly report, Q1 2020 — revenue $4.36B (+5% y/y), net income $69.0M, EPS $0.06 |
| Apr 22, 2020DEFA14A | Additional proxy materials |
| Apr 22, 2020DEF 14A | Proxy statement |
| Mar 19, 2020PRE 14A | Preliminary proxy statement |
| Feb 21, 202010-K | Annual report, FY2019 — revenue $16.89B (−8% y/y), net income −$999.0M, EPS −$0.91 |
6 current reports (8-K) not listed; the year is on EDGAR.
2019 · 17 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 7, 201910-Q | Quarterly report, Q3 2019 — revenue $4.09B (−7% y/y), net income −$314.0M, EPS −$0.29 |
| Aug 7, 201910-Q | Quarterly report, Q2 2019 — revenue $4.18B (−8% y/y), net income −$689.0M, EPS −$0.63 |
| May 2, 201910-Q | Quarterly report, Q1 2019 — revenue $4.15B (−16% y/y), net income −$105.0M, EPS −$0.10 |
| Apr 16, 2019DEFA14A | Additional proxy materials |
| Apr 16, 2019DEF 14A | Proxy statement |
| Feb 19, 201910-K | Annual report, FY2018 — revenue $18.27B (−16% y/y), net income −$2.15B, EPS −$2.35 |
11 current reports (8-K) not listed; the year is on EDGAR.
2018 · 20 filings — 14 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 1, 201810-Q | Quarterly report, Q3 2018 — revenue $4.38B (−22% y/y), net income −$208.0M, EPS −$0.27 |
| Aug 2, 201810-Q | Quarterly report, Q2 2018 — revenue $4.55B (−20% y/y), net income −$176.0M, EPS −$0.24 |
| May 3, 201810-Q | Quarterly report, Q1 2018 — revenue $4.92B (−13% y/y), net income $1.12B, EPS $1.03 |
| Apr 25, 2018DEFA14A | Additional proxy materials |
| Apr 25, 2018DEF 14A | Proxy statement |
| Feb 12, 201810-K | Annual report, FY2017 — revenue $21.85B (−0% y/y), net income −$16.27B, EPS −$16.26 |
14 current reports (8-K) not listed; the year is on EDGAR.
2017 · 90 filings — 89 × 6-K, 1 × 20-F
2016 · 101 filings — 99 × 6-K, 1 × 20-F, 1 × 6-K/A
Counted, not listed; the year is on EDGAR.
2015 · 111 filings — 110 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2014 · 93 filings — 91 × 6-K, 1 × 20-F, 1 × 6-K/A
Counted, not listed; the year is on EDGAR.
2013 · 87 filings — 86 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2012 · 75 filings — 74 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2011 · 82 filings — 81 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2010 · 78 filings — 77 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2009 · 67 filings — 66 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2008 · 113 filings — 112 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2007 · 71 filings — 70 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2006 · 89 filings — 88 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2005 · 75 filings — 74 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2004 · 74 filings — 73 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2003 · 60 filings — 58 × 6-K, 1 × 20-F, 1 × 6-K/A
Counted, not listed; the year is on EDGAR.
2002 · 43 filings — 40 × 6-K, 2 × 6-K/A, 1 × 40-F
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 116 filings — 72 × 4, 32 × 144, 2 × 3 and 8 other forms
| Filed | What it is |
|---|---|
| Oct 8, 20263 | Initial insider holdings (Form 3) |
| Sep 22, 20264 | Insider transaction (Form 4) |
| Sep 22, 20264 | Insider transaction (Form 4) |
| Sep 21, 2026144 | Notice of proposed sale (Form 144) |
| Sep 18, 2026144 | Notice of proposed sale (Form 144) |
| Sep 14, 20268-A12B/A | Exchange listing registration, amended |
| Sep 14, 202625-NSE | Delisting notice from the exchange |
| Sep 11, 2026424B5 | Prospectus supplement |
| Sep 10, 2026FWP | Free writing prospectus |
| Sep 10, 2026FWP | Free writing prospectus |
| Sep 8, 2026424B5 | Prospectus supplement |
| Aug 25, 20264 | Insider transaction (Form 4) |
| Aug 25, 20264 | Insider transaction (Form 4) |
| Aug 19, 20264 | Insider transaction (Form 4) |
| Aug 17, 2026144 | Notice of proposed sale (Form 144) |
| Aug 10, 20264 | Insider transaction (Form 4) |
| Aug 5, 20264 | Insider transaction (Form 4) |
| Aug 5, 20264 | Insider transaction (Form 4) |
| Aug 3, 2026144 | Notice of proposed sale (Form 144) |
| Aug 3, 2026144 | Notice of proposed sale (Form 144) |
| Jul 29, 2026F-6 POS | Other filings |
| Jun 22, 20264 | Insider transaction (Form 4) |
| Jun 18, 2026144 | Notice of proposed sale (Form 144) |
| Jun 16, 20264 | Insider transaction (Form 4) |
| Jun 11, 2026144 | Notice of proposed sale (Form 144) |
The newest 25 of 116 shown; the full year is on EDGAR.
2025 · 99 filings — 58 × 4, 24 × 144, 3 × SCHEDULE 13G and 9 other forms
| Filed | What it is |
|---|---|
| Dec 18, 20254 | Insider transaction (Form 4) |
| Dec 18, 20254 | Insider transaction (Form 4) |
| Dec 12, 2025144 | Notice of proposed sale (Form 144) |
| Dec 11, 20254 | Insider transaction (Form 4) |
| Dec 11, 20254 | Insider transaction (Form 4) |
| Dec 9, 2025144 | Notice of proposed sale (Form 144) |
| Dec 9, 2025144 | Notice of proposed sale (Form 144) |
| Dec 4, 20254 | Insider transaction (Form 4) |
| Dec 1, 20254 | Insider transaction (Form 4) |
| Nov 26, 2025144 | Notice of proposed sale (Form 144) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 20, 2025144 | Notice of proposed sale (Form 144) |
| Nov 18, 20254 | Insider transaction (Form 4) |
| Nov 14, 2025144 | Notice of proposed sale (Form 144) |
| Nov 10, 20254 | Insider transaction (Form 4) |
| Nov 10, 20254 | Insider transaction (Form 4) |
| Nov 6, 2025144/A | Notice of proposed sale (Form 144), amended |
| Nov 5, 2025SCHEDULE 13G/A | Other filings |
| Oct 6, 2025SCHEDULE 13G | Other filings |
| Sep 12, 2025144 | Notice of proposed sale (Form 144) |
| Sep 9, 20254 | Insider transaction (Form 4) |
| Aug 6, 2025SCHEDULE 13G/A | Other filings |
| Aug 5, 20254 | Insider transaction (Form 4) |
| Aug 5, 20254 | Insider transaction (Form 4) |
| Aug 1, 2025144 | Notice of proposed sale (Form 144) |
The newest 25 of 99 shown; the full year is on EDGAR.
2024 · 84 filings — 64 × 4, 7 × 144, 4 × 3 and 6 other forms
| Filed | What it is |
|---|---|
| Dec 26, 20244 | Insider transaction (Form 4) |
| Dec 20, 2024144 | Notice of proposed sale (Form 144) |
| Dec 4, 20244 | Insider transaction (Form 4) |
| Dec 4, 20243 | Initial insider holdings (Form 3) |
| Nov 21, 20244 | Insider transaction (Form 4) |
| Nov 20, 2024144 | Notice of proposed sale (Form 144) |
| Nov 12, 2024SC 13G | Passive holder above 5% (Schedule 13G) |
| Sep 4, 20244 | Insider transaction (Form 4) |
| Aug 14, 2024144/A | Notice of proposed sale (Form 144), amended |
| Aug 14, 2024144/A | Notice of proposed sale (Form 144), amended |
| Aug 13, 20244 | Insider transaction (Form 4) |
| Aug 13, 20244 | Insider transaction (Form 4) |
| Aug 13, 20244 | Insider transaction (Form 4) |
| Aug 12, 2024144 | Notice of proposed sale (Form 144) |
| Aug 12, 2024144 | Notice of proposed sale (Form 144) |
| Aug 9, 2024144 | Notice of proposed sale (Form 144) |
| Aug 5, 20244 | Insider transaction (Form 4) |
| Aug 5, 20244 | Insider transaction (Form 4) |
| Aug 5, 20243 | Initial insider holdings (Form 3) |
| Aug 1, 2024144 | Notice of proposed sale (Form 144) |
| Jun 21, 20244 | Insider transaction (Form 4) |
| Jun 18, 2024144 | Notice of proposed sale (Form 144) |
| Jun 17, 20244 | Insider transaction (Form 4) |
| Jun 17, 20244 | Insider transaction (Form 4) |
| Jun 17, 20244 | Insider transaction (Form 4) |
The newest 25 of 84 shown; the full year is on EDGAR.
2023 · 72 filings — 58 × 4, 6 × 3, 2 × 424B5 and 5 other forms
Counted, not listed; the year is on EDGAR.
2022 · 67 filings — 58 × 4, 3 × UPLOAD, 2 × CORRESP and 4 other forms
Counted, not listed; the year is on EDGAR.
2021 · 94 filings — 78 × 4, 5 × 3, 2 × SC 13G/A and 8 other forms
Counted, not listed; the year is on EDGAR.
2020 · 99 filings — 76 × 4, 5 × S-8 POS, 4 × CORRESP and 9 other forms
Counted, not listed; the year is on EDGAR.
2019 · 76 filings — 71 × 4, 2 × SC 13G/A, 1 × 3 and 2 other forms
Counted, not listed; the year is on EDGAR.
2018 · 113 filings — 61 × 4, 25 × 3, 5 × 3/A and 12 other forms
Counted, not listed; the year is on EDGAR.
2017 · 11 filings — 3 × SC 13D/A, 2 × SC 13G/A, 2 × UPLOAD and 4 other forms
Counted, not listed; the year is on EDGAR.
2016 · 13 filings — 4 × FWP, 2 × 424B5, 2 × S-8 and 4 other forms
Counted, not listed; the year is on EDGAR.
2015 · 20 filings — 4 × 424B5, 3 × SC TO-T/A, 2 × F-3ASR and 9 other forms
Counted, not listed; the year is on EDGAR.
2014 · 13 filings — 4 × SC TO-T/A, 3 × CORRESP, 2 × UPLOAD and 4 other forms
Counted, not listed; the year is on EDGAR.
2013 · 8 filings — 5 × CORRESP, 3 × UPLOAD
Counted, not listed; the year is on EDGAR.
2012 · 16 filings — 4 × CORRESP, 3 × UPLOAD, 2 × 424B5 and 7 other forms
Counted, not listed; the year is on EDGAR.
2011 · 15 filings — 4 × 424B5, 3 × FWP, 2 × CORRESP and 4 other forms
Counted, not listed; the year is on EDGAR.
2010 · 10 filings — 3 × CORRESP, 2 × 424B5, 2 × UPLOAD and 3 other forms
Counted, not listed; the year is on EDGAR.
2009 · 8 filings — 2 × CORRESP, 2 × SC 13G, 2 × SC 13G/A and 1 other form
Counted, not listed; the year is on EDGAR.
2008 · 32 filings — 9 × 425, 6 × CORRESP, 3 × UPLOAD and 11 other forms
Counted, not listed; the year is on EDGAR.
2007 · 8 filings — 2 × CORRESP, 2 × SC 13G/A, 2 × UPLOAD and 2 other forms
Counted, not listed; the year is on EDGAR.
2006 · 18 filings — 6 × 424B5, 5 × 425, 3 × FWP and 4 other forms
Counted, not listed; the year is on EDGAR.
2005 · 21 filings — 12 × 425, 1 × 3, 1 × F-3ASR and 7 other forms
Counted, not listed; the year is on EDGAR.
2004 · 9 filings — 3 × S-8, 2 × 424B3, 2 × 424B5 and 2 other forms
Counted, not listed; the year is on EDGAR.
2003 · 16 filings — 6 × 424B3, 2 × F-3, 1 × 3 and 7 other forms
Counted, not listed; the year is on EDGAR.
2002 · 10 filings — 5 × 424B3, 1 × F-3, 1 × POS AM and 3 other forms
Counted, not listed; the year is on EDGAR.
2001 · 1 filing — 1 × SC 13G/A
Counted, not listed; the year is on EDGAR.
2000 · 1 filing — 1 × SC 13G/A
Counted, not listed; the year is on EDGAR.
1999 · 4 filings — 2 × SC 14D1/A, 1 × SC 13G, 1 × SC 14D1
Counted, not listed; the year is on EDGAR.
1996 · 1 filing — 1 × SC 13D
Counted, not listed; the year is on EDGAR.
About this data#
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) has 2,517 filings on EDGAR going back to 1996: 25 annual reports, 26 quarterly reports and 1,385 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 3, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Sep 16, 2026, covered material definitive agreement; new financial obligation. Over the last 13 months insiders sold $93.2M in 37 sales and bought nothing on the open market; 109 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been Teva Pharmaceutical Industries Limited American Depositary Shares, read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read TEVA's latest 10-K?
- TEVA's latest annual report, a 10-K, was filed on Feb 3, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did TEVA last file an 8-K?
- On Sep 16, 2026 it covered material definitive agreement; new financial obligation. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Jul 29, 2026.
- Are TEVA insiders buying or selling?
- Over the last 13 months insiders sold $93.2M in 37 sales and bought nothing on the open market; 109 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: MIGNONE ROBERTO (Director) sold 367,600 shares on Sep 18, 2026 for $14.4M. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has TEVA made?
- 2,517 filings are on EDGAR under the registrant records that have been Teva Pharmaceutical Industries Limited American Depositary Shares, going back to 1996; 724 of them are insider ownership forms (Forms 3, 4, 5 and 144).